metoprolol tartrate
/ Generic mfg.
- LARVOL DELTA
Home
Next
Prev
1 to 25
Of
1139
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
December 06, 2025
HEART-BEAT: Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease
(clinicaltrials.gov)
- P2/3 | N=350 | Not yet recruiting | Sponsor: Gødstrup Hospital
New P2/3 trial • Cardiovascular • Coronary Artery Disease • Heart Failure
August 30, 2025
Acute Onset of Achalasia in a Patient With Metoprolol Initiation
(ACG 2025)
- "The patient declined repeat manometry. This case described a patient with acute onset of type III achalasia after initiation of metoprolol tartrate, with complete resolution after switching to carvedilol. Further studies are warranted to explore the effects of different BB formulations on EGJOO.Figure: Figure 1 – Repeat Barium Esophagram on day 17 with dilated esophagus and disorganized peristalsis. Figure: Figure 2 - High Resolution Manometry Performed on Day 18 Showed Elevated LES Integrated Relaxation Pressure and Shortened Distal Latency."
Clinical • Cardiovascular • Gastrointestinal Disorder • Myocardial Infarction • Rare Diseases
July 01, 2025
AORTIC DISSECTION IN AUTOIMMUNE HEPATITIS: THE INFLAMMATORY LINK TO CATASTROPHIC VASCULAR EVENTS
(CHEST 2025)
- "CASE PRESENTATION: A 69-year-old female with a history of MS and AIH on azathioprine presented to the emergency department (ED) with acute severe headache, confusion, and upper extremity heaviness...An esmolol drip was initiated per protocol and cardiothoracic surgery was consulted, she was then emergently transferred to a tertiary center for surgery...Intraoperative biopsy of the aorta showed hemorrhage with mixed acute and chronic inflammation.Her post-operative course was complicated by new-onset atrial fibrillation requiring amiodarone which was later transitioned to Lopressor and volume overload with hypoxic respiratory failure necessitating BiPAP and heated high-flow oxygen therapy... This case underscores a rare occurrence of aortic dissection in a patient with AIH and MS. While traditional risk factors were absent, underlying autoimmune inflammation may have contributed. Further studies are necessary to clarify the association between autoimmune diseases and..."
Atherosclerosis • Atrial Fibrillation • Autoimmune Hepatitis • Cardiovascular • CNS Disorders • Hematological Disorders • Hepatology • Hypertension • Immunology • Inflammation • Inflammatory Arthritis • Lupus • Multiple Sclerosis • Respiratory Diseases • Rheumatoid Arthritis • Rheumatology • Systemic Lupus Erythematosus
July 01, 2025
SUICIDE ATTEMPT VIA OVERT FLECAINIDE OVERDOSE
(CHEST 2025)
- "During her stay in CCU, patient converted into AFib with RVR, uncontrolled with Metoprolol Tartrate 5mg x3 and was subsequently started on Diltiazem drip. Given how rare flecainide toxicity is in clinical practice, it is important to have a high index of suspicion anti-arrhythmogenic overdose in patients presenting with cardiac conduction abnormalities and prior atrial fibrillation, especially in those with psychiatric comorbidities. The mainstay of treatment remains supportive care, sodium bicarbonate supplementation, and where appropriate, lipid emulsion."
Atrial Fibrillation • Cardiovascular • CNS Disorders • Depression • Nephrology • Psychiatry • Renal Disease • Respiratory Diseases • Ventricular Tachycardia
July 01, 2025
FLECAINIDE FALLOUT: NAVIGATING WIDE, COMPLEX TACHYCARDIA AND PACEMAKER CAPTURE LOSS
(CHEST 2025)
- "CASE PRESENTATION: An 81-year-old female with a past medical history of paroxysmal atrial fibrillation (AF) on metoprolol tartrate, and flecainide, sick sinus syndrome (SSS) status post (s/p) Boston Scientific dual chamber permanent pacemaker presented with complaints of lethargy and dizziness...Additional treatments may include antiarrhythmics like amiodarone or lidocaine, intravenous fat emulsion, or pacing for bradyarrhythmias... Flecainide toxicity is diagnosed clinically, and drug levels are not necessary for diagnosis since it takes time for results to be available. Prior to starting flecainide therapy, pacemaker settings should be adjusted as the drug can improve ventricular capture. However, flecainide toxicity can increase the risk of pacemaker failure by raising the capture threshold."
Acute Kidney Injury • Atrial Fibrillation • Cardiovascular • CNS Disorders • Epilepsy • Hepatology • Hypotension • Nephrology • Renal Disease • Ventricular Tachycardia
July 01, 2025
A NEW HURDLE: NEW-ONSET ATRIAL FIBRILLATION IN JEUNE THORACIC DYSTROPHY
(CHEST 2025)
- "On the second day of admission, developed new-onset atrial fibrillation (AF) with rapid ventricular response and was treated with digoxin and amiodarone...For his paroxysmal AF, the patient was discharged with Eliquis for stroke prophylaxis and metoprolol tartrate for rate control... This case highlights the potential for cardiac complications in patients with rare skeletal dysplasia that leads a restrictive lung disease. While Jeune thoracic dystrophy mainly affects his respiratory function, the complication of his chronic respiratory failure plays a part in the development of his new-onset AF. This underscores the importance of monitoring cardiac function in older patients with Jeune thoracic dystrophy."
Atrial Fibrillation • Cardiovascular • CNS Disorders • Congestive Heart Failure • Depression • Heart Failure • Hepatology • Hypotension • Infectious Disease • Liver Failure • Orthopedics • Pneumonia • Psychiatry • Pulmonary Disease • Respiratory Diseases
September 23, 2025
When Pain Puts Your Heart in the Fast Lane: A Case of Ventricular Tachycardia Induced by Pain From Rib Fracture.
(PubMed, Cureus)
- "She was evaluated by electrophysiology, who recommended initiating metoprolol tartrate, as the working diagnosis was thought to be RMVT. She underwent cardiac catheterization, which showed non-obstructive coronary artery disease (CAD). Upon further evaluation, she was found to have right-sided rib fractures that were not seen on the initial workup...Her tachycardia was resolved with beta blockers. The patient was discharged in a stable condition with electrophysiology follow-up for considering ablation."
Journal • Back Pain • Cardiomyopathy • Cardiovascular • Coronary Artery Disease • Heart Failure • Musculoskeletal Diseases • Musculoskeletal Pain • Orthopedics • Pain • Ventricular Tachycardia
September 18, 2025
Antimicrobial Stability, pH, and Physical Appearance of Cardiovascular Drug Suspensions in SyrSpend® SF PH4: A Complementary Evaluation.
(PubMed, Int J Pharm Compd)
- "Nine oral formulations of seven cardiovascular drug suspensions were included: amlodipine (as besylate) 1.0 mg/mL, enalapril maleate 1.0 mg/mL, hydrochlorothiazide 2.0 and 5.0 mg/mL, lisinopril (as dihydrate) 1.0 mg/mL, metoprolol tartrate 10.0 mg/mL, pentoxifylline 20.0 mg/mL, and spironolactone 2.0 and 2.5 mg/mL. All formulations met USP criteria for antimicrobial effectiveness, while maintaining stable pH values and no relevant changes in physical appearance throughout the study. These results, when combined with previously demonstrated chemical stability (HPLC), confirm that SyrSpend® SF PH4 is a robust and reliable vehicle for preservative-free extemporaneous oral liquid formulations, supporting its safe use within USP-compliant BUD limits."
Journal • Cardiovascular • Pediatrics
September 18, 2025
Stability Study of Pediatric Oral Suspensions Formulated with PCCA SuspendIt Vehicle Used for the Treatment of Cardiovascular Disease.
(PubMed, Int J Pharm Compd)
- "The current study demonstrates that SuspendIt cardiovascular suspensions are physically, chemically and microbiologically stable for 180 days for captopril (when stored in the refrigerator) and hydrochlorothiazide and metoprolol tartrate (when stored at room temperature), retaining not less than 90% of the labeled drug concentrations. This study provides a viable compounded alternative for hydrochlorothiazide, metoprolol tartrate and captopril in a liquid dosage form with an adequate beyond-use-date to meet patient needs."
Journal • Cardiovascular • Pediatrics
May 15, 2025
Optimizing heart rate with metoprolol prior to coronary CT angiography: a dose-response analysis in a large cohort
(ESC-WCC 2025)
- "Patients were categorized based on the applied metoprolol preparation strategy: group 1, no metoprolol; group 2, metoprolol succinate 1-3 days before CCTA; group 3, metoprolol tartrate at the intake of CCTA; group 4, succinate and additional tartrate before CCTA. Tartrate was more effective, particularly in patients without prior succinate preparation. Doses of 100 mg are recommended for most patients with an HR >65 bpm, further guided by patient characteristics."
Cardiovascular • Coronary Artery Disease
July 14, 2025
BEACON: Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA
(clinicaltrials.gov)
- P4 | N=46 | Recruiting | Sponsor: VZW Cardiovascular Research Center Aalst | Initiation date: Mar 2025 ➔ Jul 2025 | Not yet recruiting ➔ Recruiting
Enrollment open • Trial initiation date • Cardiovascular • Coronary Artery Disease
July 31, 2025
Diagnostic Value of Exercise Stress Testing Combined With Beta-Blocker Therapy (Metoprolol) in Hypertensive Patients With Suspected Coronary Artery Disease.
(PubMed, Cureus)
- "In hypertensive patients with suspected CAD, combining EST with metoprolol provides a viable and non-invasive diagnostic strategy, offering high specificity and PPV despite moderate sensitivity."
Journal • Cardiovascular • Coronary Artery Disease • Hypertension
July 29, 2025
The impact of glidant addition on continuous blending of active pharmaceutical ingredients.
(PubMed, Int J Pharm)
- "Two cohesive APIs (acetaminophen micronized and metoprolol tartrate) and three different glidants (Aerosilprotect relax special {t4ht=®} 200, Aerosilprotect relax special {t4ht=®} R972 and Syloidprotect relax special {t4ht=®} 244 FP) were included...Moreover, adding higher concentrations of glidants can even increase RSDBU due to fluidization segregation and less paddle interactions. However, overall the RSDBU values obtained with the continuous blender were relatively low."
Journal
April 27, 2025
Hyperthyroidism to Heart Failure: Armour Thyroid as a Catalyst for Takotsubo Cardiomyopathy
(ENDO 2025)
- "The patient was started on metoprolol tartrate, and Armour Thyroid was discontinued, replaced by Levothyroxine 75 mcg daily. This case underscores the need to recognize Armour Thyroid-induced hyperthyroidism as a potential cause of TC. A comprehensive diagnostic approach and prompt intervention are crucial for optimal patient outcomes."
Cardiomyopathy • Cardiovascular • Congestive Heart Failure • Coronary Artery Disease • Endocrine Disorders • Heart Failure • Myocardial Infarction • Pain • Psychiatry
April 27, 2025
Metastatic Pheochromocytoma and Neuroendocrine Breast Cancer in a Young Woman
(ENDO 2025)
- "Doxazosin 1 mg nightly and a high sodium diet were started and slowly increased to 5 mg every 12 hours over 14 days preop. Metoprolol tartrate was added after adequate alpha blockade... Cases of concurrent pheochromocytoma and neuroendocrine breast cancer remain rare. Few case studies show metastatic pheochromocytoma to the breast. Both pheochromocytoma and neuroendocrine breast cancer have been associated with several familial conditions, including Von-Hippel-Lindau, neurofibromatosis 1, and MEN2."
Clinical • Metastases • Breast Cancer • Cardiovascular • Diabetes • Endocrine Cancer • Genetic Disorders • Hormone Receptor Positive Breast Cancer • Hypertension • Neuroendocrine Carcinoma • Neuroendocrine Tumor • Neurofibromatosis • Oncology • Pain • Solid Tumor • Von Hippel-Lindau Syndrome • PGR
June 24, 2025
Transient worsening of thyrotoxic myopathy following methimazole and metoprolol initiation in a 12-year-old girl: a case report and literature review.
(PubMed, J Pediatr Endocrinol Metab)
- "TM may show transient worsening after MMI and metoprolol tartrate administration, requiring the evaluation of TM, drug side effects, and other possible causes before continuing treatment. This case highlights the importance of recognizing TM in pediatric patients."
Journal • CNS Disorders • Endocrine Disorders • Grave’s Disease • Immunology • Muscular Atrophy • Myasthenia Gravis • Myositis • Pediatrics
June 11, 2025
FDA endorses 10 more drug products for VAT exemption
(Manila Bulletin)
- "The newly endorsed VAT-exempt drugs are as follows: High cholesterol: Atorvastatin (as calcium) + Fenobribrate 20 mg/160 mg; Cancer: Tegafur + Gimeracil + Oteracil Potassium 20 mg/5.8 mg/19.6 mg and Tegafur + Gimeracil + Oteracil Potassium 25 mg/7.25 mg/24.5 mg; Diabetes: Metformin Hydrochloride + Teneligliptin (as hydrobromide hydrate) 1 g/20 mg and Metformin Hydrochloride + Teneligliptin (as hydrobromide hydrate) 500 mg/20 mg; Hypertension: Metoprolol tartrate + Ivabradine (as hydrochloride) 50 mg/5 mg and Metoprolol tartrate + Ivabradine (as hydrochloride) 25 mg/5 mg; Hypertension: Metoprolol tartrate + Ivabradine (as hydrochloride) 50 mg/5 mg and Metoprolol tartrate + Ivabradine (as hydrochloride) 25 mg/5 mg; Mental illness: Lamotrigine 5 mg (dispersible/chewable tablet), Lamotrigine 25 mg (oral dispersible tablet), and Lamotrigine 25 mg (tablet)"
Commercial • FDA event • Breast Cancer • CNS Disorders • Colorectal Cancer • Diabetes • Dyslipidemia • Gastric Cancer • Hypertension • Non Small Cell Lung Cancer • Prostate Cancer • Renal Cell Carcinoma
May 28, 2025
Simultaneous Determination of Glibenclamide, Metoprolol Tartrate, and Phenol Red Using HPLC-PDA: Application in Rat Intestinal Permeability Studies and Its Greenness Assessment Using NEMI, Analytical Eco-Scale, GAPI, MoGAPI, AGREE, AGREEprep, RAPI, BAGI, and CACI.
(PubMed, Biomed Chromatogr)
- No abstract available
Journal • Preclinical
February 24, 2025
Explosive Pleuritis and Parapneumonic Effusion: A Group A Streptococcus-induced Pneumonia Crisis
(ATS 2025)
- "Case report: A 57-year-old male with a history of hypertension, gout, and asthma presented with worsening shortness of breath after been diagnosed with influenza and started on Tamiflu two days back...He was treated with ceftriaxone, azithromycin, clindamycin, steroids, and nebulization. During his hospital stay, he developed atrial fibrillation with rapid ventricular response, which was managed with Eliquis and Lopressor. A repeat chest x-ray showed bilateral ill-defined opacities, prompting escalation of antibiotics to Zosyn, while he completed a 3-day course of clindamycin...Explosive pleuritis may confer higher morbidity and mortality, thus early recognition and treatment is imperative. Thoracocentesis and pleural fluid analysis with early chest tube drainage is necessary with unresolved cases needing surgical interventions."
Asthma • Atrial Fibrillation • Cardiovascular • Gout • Heart Failure • Hypertension • Immunology • Infectious Disease • Inflammatory Arthritis • Influenza • Pneumonia • Respiratory Diseases • Rheumatology
May 19, 2025
Metoprolol removal and mineralization by TiO2 and iron pillared clay nanocomposite: Impact of operating parameters, water matrices, and solar light.
(PubMed, J Environ Manage)
- "This study investigates the photocatalytic degradation of metoprolol tartrate (MET) using TiO2 nanostructures supported on Fe pillared activated bentonite (FeAB) under UV, visible, and solar irradiation...Total Organic Carbon (TOC) measurement showed 73 %, 100 %, and 76 % mineralization after 10 h under UV, visible, and solar light, respectively. The TiO2/FeAB composite exhibited excellent stability and reusability, highlighting its potential as a clean technology for pharmaceutical removal from diverse water sources."
Journal
April 14, 2025
Predicting Conversion From Unipolar Depression to Bipolar Disorder and Schizophrenia: A 10-Year Retrospective Cohort Study on 12,182 Inpatients.
(PubMed, Depress Anxiety)
- "Higher risk factors for BD progression included being female, having severe depression, being prescribed mood stabilizers, β receptor blockers (e.g., metoprolol tartrate and propranolol hydrochloride), and antipsychotics (e.g., sulpiride and quetiapine). Higher risk factors for SCZ progression included being male, exhibiting psychotic symptoms, being prescribed antipsychotics (e.g., risperidone and sulpiride), antiside effects drugs (e.g., trihexyphenidyl and hemp seed pill), and undergoing psychotherapy...A key finding is that individuals with refractory (particularly psychotic) UD had an elevated risk of transitioning to BD and SCZ, with social-demographic factors, lifestyle behaviors, vital signs, and blood markers becoming significant risk factors over follow-up. Upon further validation, these models could provide clinicians with dynamic information regarding a patient's risk of disease conversion."
Journal • Retrospective data • Bipolar Disorder • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry • Schizophrenia
January 28, 2025
SAM STRIKES BACKWARDS: MAVACAMTEN'S ROLE IN POSTERIOR LEAFLET SYSTOLIC ANTERIOR MOTION OF THE MITRAL VALVE - Sri Nuvvula
(ACC 2025)
- "Despite beta-blockade (metoprolol tartrate 50 mg twice daily), LVOT gradient remained elevated (74 mmHg with Valsalva) on echocardiography (Figure 1A, 1B). This case highlights mavacamten's efficacy in reducing dynamic LVOT obstruction in HoCM in the setting of posterior leaflet SAM."
Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Obstructive Hypertrophic Cardiomyopathy • Pulmonary Disease
March 07, 2025
BEACON: Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA: a Randomised, Placebo-controlled, Mechanistic Study
(clinicaltrials.gov)
- P4 | N=46 | Not yet recruiting | Sponsor: VZW Cardiovascular Research Center Aalst
New P4 trial • Cardiovascular • Coronary Artery Disease
February 13, 2025
Profound hypotension following concomitant administration of tizanidine and lisinopril.
(PubMed, BMJ Case Rep)
- "Pertinent medication history included metoprolol tartrate, lisinopril, hydralazine, hydrochlorothiazide and tizanidine and was continued. This reaction scored a 4 on the Naranjo Adverse Drug Reaction Probability Scale and Drug Interaction Probability Scale. Providers should be aware of this potential adverse reaction from the combination of medications."
Journal • Back Pain • Cardiovascular • Hypertension • Hypotension • Musculoskeletal Pain • Pain
February 05, 2025
ORION: Metoprolol to Reduce Perioperative Myocardial Injury
(clinicaltrials.gov)
- P3 | N=72 | Completed | Sponsor: University of Chicago | N=170 ➔ 72
Enrollment change • Cardiovascular • Heart Failure
1 to 25
Of
1139
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46